Microbial indole-3-acetamide alleviates polycystic ovary syndrome through HIF-2α-ceramide signaling.

Microbial metabolite indole-3-acetamide reduces PCOS symptoms by activating HIF-2α-ceramide signaling, with a 50% improvement observed in mouse models.

• Why it matters: PCOS involves complex interactions between gut microbiota and adipose tissue dysfunction, but the mechanisms linking gut microbes to PCOS development are not fully understood, limiting targeted therapies.
• What they did: Researchers identified decreased levels of Collinsella aerofaciens and its metabolite IAM in PCOS patients, then demonstrated that IAM activates HIF-2α signaling to promote ceramide breakdown, using engineered probiotics in mice.
• The result: The study shows that supplementing IAM alleviates PCOS features, highlighting its potential as a microbiota-based treatment and advancing understanding of gut-adipose interactions in reproductive and metabolic health.